Added to YB: 2025-02-05
Pitch date: 2025-01-28
ONC [bullish]
BeOne Medicines AG
+42.05%
current return
Author Info
Bamboo Works provides news on Chinese companies listed in Hong Kong and the United States. Sign up for the newsletter.
Company Info
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
Market Cap
$40.5B
Pitch Price
$224.61
Price Target
N/A
Dividend
N/A
EV/EBITDA
108.94
P/E
625.64
EV/Sales
7.53
Sector
Biotechnology
Category
growth
Bamboo Works Weekly: BeiGene heads for profit milestone after hemorrhaging cash
ONC: BeiGene expects operating profit in 2024, driven by blockbuster cancer drug. Revenue to exceed R&D costs. Stock range $126.97-$248.16. US-China tensions impact tech firms, export controls, IPOs. TSMC benefits from AI boom, faces US manufacturing pressure. Property crisis deepens with Sunac liquidation suit.
Read full article (4 min)